US Patent Issued to THE BROAD INSTITUTE, PRESIDENT AND FELLOWS OF HARVARD COLLEGE, New York University on Sept. 29 for "Interneuron-specific therapeutics for normalizing neuronal cell excitability and treating Dravet syndrome" (Massachusetts, New York Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,452, issued on Sept. 29, was assigned to THE BROAD INSTITUTE INC. (Cambridge, Mass.), PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, Mass.) and New York University (New York).

"Interneuron-specific therapeutics for normalizing neuronal cell excitability and treating Dravet syndrome" was invented by Jordane Dimidschstein (Cambridge, Mass.), Gordon Fishell (Cambridge, Mass.) and Orrin Devinsky (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are therapeutic virus vectors, particularly, recombinant adeno-associated virus (rAAV) vectors, designed to contain an enhancer sequence that specifically restricts expression of an effecto...